← Evidence map

ArticleFrontiers in immunology2026

Clinical-scale 10-day TCR-T cell manufacturing using IL-2/7/15 and TGF-β promotes early memory and tissue-resident-like phenotypes and robust antitumor activity

Yi-Ping Shih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Clinical-scale 10-day TCR-T cell manufacturing using IL-2/7/15 and TGF-β promotes early memory and tissue-resident-like phenotypes and robust antitumor activity | OpenQuestion